#USA #Memphis #Childhood Cancer #St. Jude #WHO

St. Jude's New Milestone in Childhood Cancer Care

In a pivotal moment for pediatric oncology, St. Jude Children's Research Hospital, located in Memphis, TN, has been officially redesignated as a WHO Collaborating Centre for Childhood Cancer. This acknowledgment signifies not only St. Jude’s extensive contributions to global health efforts in treating childhood cancer but also marks a decisive step forward in collaboration with the World Health Organization (WHO).

The designation affirms the hospital's dedication to advancing cancer care for children, ensuring that geographical barriers do not determine treatment access or outcomes. Dr. James R. Downing, president and CEO of St. Jude, emphasized the philosophy driving their work: children's healthcare should never be contingent on where they live. The institution's active partnerships with various governments and healthcare organizations aim to enhance cancer care quality and health systems worldwide.

St. Jude is unique, being the sole WHO Collaborating Centre devoted entirely to childhood cancer among over 800 such centers in more than 80 countries. Since launching in 2018, this center has provided WHO with essential strategic, scientific, and technical expertise. This has involved contributions to national policy, fostering education, and establishing multisectoral partnerships among hospitals, foundations, and global entities to enhance childhood cancer care.

As part of its expansive efforts, St. Jude collaborates with its own global network, the St. Jude Global Alliance, which includes over 400 partnerships across 90 nations. This extensive network has created a robust implementation framework, enhancing its capacity to assist WHO in shaping scientific advancements and health systems affecting pediatric cancer treatment globally.

The partnership between St. Jude and WHO facilitated significant initiatives such as the Global Initiative for Childhood Cancer (GICC) launched in 2018, aimed at increasing the survival rate of children with cancer to at least 60% by 2030. To complement this initiative, the newly implemented Global Platform for Access to Childhood Cancer Medicines has been established, reflecting a collective determination to better health outcomes for young patients around the world.

The redesignated work plan emphasizes contributions supporting WHO in different realms, including policy development, systems science, and palliative care management for other critical pediatric conditions like sickle cell disease. Dr. Carlos Rodriguez-Galindo expressed the ambitious goals of this partnership, aiming for a transformational increase in pediatric cancer survival rates in regions where current survival rates fall below 30%.

Dr. Catherine Lam, the director of the WHO Collaborating Centre for Childhood Cancer, reiterated the significance of collaboration in strengthening health systems through sharing best practices and technical support. St. Jude's expertise in national cancer control planning integrates the nuances of pediatric oncology with broader health frameworks, ensuring children, adolescents, and young adults receive the specific attention they deserve in global health discussions.

Moreover, alongside its recent designation, St. Jude also serves as one of seven WHO Collaborating Centres for Influenza, reinforcing its pivotal role in addressing various health challenges comprehensively.

The mission of St. Jude Children's Research Hospital, since its inception in 1962, has revolved around promoting survival and quality of life for children facing life-threatening conditions like cancer and sickle cell disease. Pioneering innovative treatments has significantly contributed to elevating the childhood cancer survival rate in the U.S. from a mere 20% to an impressive over 80% today.

Through its collaboration with WHO, St. Jude not only aims to broaden its impact in the local realm but aspires to extend its lifesaving mission globally. As efforts continue to unite resources and expertise for pediatric oncology care, dedicated initiatives emphasize the vision of ensuring every child benefits from high-quality, compassionate cancer care around the world.

For more information about St. Jude's innovative work and global initiatives, visit St. Jude's website or follow their social updates.